Ondansetron Tablet, Orally Disintegrating
Product Images NDC 51655-809

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51655-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of Ondansetron, depicting its molecular formula with distinct rings and functional groups.*
FDA Label Image

Label (51655 809 53 Rev B 09 25 Nhc)

Label (51655 809 53   Rev B 09 25 Nhc)
Ondansetron 8 mg orally disintegrating tablets label showing the product name, strength, dosage form, package size of 10 tablets, and manufacturer Northwind Health Company, LLC. The label includes storage instructions, dosage directions, barcodes, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.